This inventor holds 30 USPTO granted patents and 31 published patent applications, plus 1 CIPO patent and 15 EPO patents, primarily in Chimeric Antigen Receptors. Top assignees: Novartis Ag, University of Pennsylvania, Beth Israel Deaconess Medical Center, Inc.. Active years: 2013-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- East Hanover, NJ (US) (2013)
- Cortlandt Manor, NY (US) (2013 - 2014)
- Cortland Manor, NY (US) (2015 - 2016)
- Cambridge, MA (US) (2013 - 2023)
Company Filing History:
30 out of 3,978 
12 out of 2,665 
2 out of 541 
Years Active: 2013-2025
Areas of Expertise:
Title: The Innovative Contributions of David Jonathan Glass
Introduction
David Jonathan Glass, based in Cambridge, MA, is an accomplished inventor with a remarkable portfolio of 29 patents. His work primarily focuses on cutting-edge medical therapies and compounds, showcasing his dedication to advancing healthcare through innovative solutions.
Latest Patents
Among his notable patents is a significant invention concerning the treatment of cancer using humanized anti-BCMA chimeric antigen receptors. This groundbreaking invention offers compositions and methods aimed at treating diseases associated with BCMA expression. It includes chimeric antigen receptors (CAR) specific to BCMA, along with vectors encoding these CARs and recombinant T cells that express them. Additionally, he has developed a patent related to rapamycin derivatives. This disclosure pertains to specific compounds and their pharmaceutically acceptable salts, and outlines methods of creating these compounds for treating various disorders and diseases.
Career Highlights
Throughout his career, David has worked with some prestigious organizations. His notable affiliations include Novartis AG and the University of Pennsylvania, where he contributed significantly to research and development efforts in the pharmaceutical field.
Collaborations
David's research initiatives have been bolstered through collaborations with esteemed colleagues such as Joan Mannick and Leon Murphy. These partnerships reflect his ability to work effectively within teams, driving innovation through shared expertise and diverse perspectives.
Conclusion
David Jonathan Glass continues to be a driving force in the realm of biomedical innovation, as evidenced by his extensive patent portfolio and contributions to significant research advancements. His work exemplifies the essence of inventiveness and determination in the pursuit of better treatments for serious medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile